跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ARX-Oxycodone/Naloxone oxycodone hydrochloride / naloxone hydrochloride 15/7.5mg modified release tablets blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
ARX-Oxycodone/Naloxone oxycodone hydrochloride / naloxone hydrochloride 15/7.5mg modified release tablets blister pack
Approved
STANDARD
ARX-Oxycodone/Naloxone oxycodone hydrochloride / naloxone hydrochloride 15/7.5mg modified release tablets blister pack
Mundipharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
21c835bface6c7c0
Company
Mundipharma Pty Ltd
Type
Standard
Approval Details
Approval Id
21c835bface6c7c0
Product Name
ARX-Oxycodone/Naloxone oxycodone hydrochloride / naloxone hydrochloride 15/7.5mg modified release tablets blister pack
Artg Id
446591
Artg Name
ARX-Oxycodone/Naloxone oxycodone hydrochloride / naloxone hydrochloride 15/7.5mg modified release tablets blister pack
Sponsor
Mundipharma Pty Ltd
Company Detail Path
/organization/mundipharma-pty-ltd
Artg Date
2024-10-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/7cb7f0a386c921c206e1747384c3e458.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/c307e3c940b8b173594be2262c9dd30f.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
21c835bface6c7c0
Type
Standard
Back to TGA Approvals